Skip to main content
Erschienen in: African Journal of Urology 1/2023

Open Access 01.12.2023 | Case Reports

Atypical presentation of testicular mesothelioma

verfasst von: Sawyer Joseph Reed, Stefanie Nasui, Nicholas Farber

Erschienen in: African Journal of Urology | Ausgabe 1/2023

Abstract

Mesothelioma is a rare cancer that generally affects the lining of the lungs. However, in more rare cases, there are extra-pleural involvement of organs that are lined with mesothelial cells, including the testicle. Mesothelioma of the tunica vaginalis of the testicle typically presents with a painless scrotal mass with accompanying hydrocele of the affected side. The most common predisposition to mesothelioma of the tunica vaginalis is previous asbestos exposure, long-standing hydrocele, and previous scrotal surgeries. In this case we present a patient with isolated left tunica vaginalis mesothelioma of the testicle, yet without classic risk factors or other sites of disease. Left radical orchiectomy was performed and subsequent follow-up imaging did not reveal any sites of recurrence or metastasis. Although, mesothelioma of the tunica vaginalis is a rare cancer, it should be seen as a possible differential when evaluating new testicular masses.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
β-HCG
Beta human chorionic gonadotropin
LDH
Lactate dehydrogenase
AFP
Alpha fetoprotein
PSA
Prostate specific antigen

1 Background

Mesotheliomas are rare tumors that generally arise after exposure to asbestos and often present in the pleura or peritoneum. However, more rarely, mesotheliomas can occur in extra-pleural tissue that is lined by mesothelial cells, such as the peritoneum and the tunica vaginalis. Mesotheliomas arising from the tunica vaginalis are rare with less than 300 documented cases and comprising less than 5% of all mesothelioma tumors [1]. Asbestos exposure is a primary risk factor for the development of mesothelioma of the tunica vaginalis, though inflammatory causes such as trauma and long-standing hydrocele are also risk factors [1, 2]. These tumors most commonly arise in middle-aged men with a mean age of 53.5 years. The clinical presentation is typically of insidious onset with unilateral painless enlargement of the scrotum with accompanying hydrocele. An important ultrasonic finding is thickening of the tunica vaginalis [3]. The overall survival in patients with mesothelioma of the tunica vaginalis is 1.5 years with a 5 year overall survival of 49% [4]. In this case report we describe a case of malignant mesothelioma without the common presentation or associated risk factors.

2 Case report

A 60-year-old male presented to a urology clinic with a left scrotal lump that had been present for “several years” but was painless and stable in size. A scrotal ultrasound was ordered and displayed a 1.5 × 1.0 cm solid mass arising from the left epididymis (Fig. 1). Serum tumor markers, alpha fetoprotein (AFP), lactate dehydrogenase (LDH), and beta human chorionic gonadotropin (β-HCG), were ordered, and all of which were negative. A left radical orchiectomy was then performed. The patient’s pathology from the radical left orchiectomy revealed malignant mesothelioma of the tunica vaginalis (Fig. 2). The tumor was measured at 3.0cm in size and all margins were negative. The patient was then sent for a computed tomography (CT) of the chest, abdomen and pelvis. The CT scan did not reveal any local adenopathy or evidence of metastatic disease. He had a repeat CT scan at 1 and 2 years postoperatively, and is currently on a surveillance protocol without any recurrence of disease after 2 years.

3 Discussion

Mesotheliomas stem from mesothelial cells which make up the lining of the pericardium, pleura, lungs, and testicles. Mostly commonly, mesotheliomas arise from exposure to asbestos. Asbestos induces DNA damage via creation of radical oxygen and nitrogen species, and iron free radicals. These in turn can cause DNA substitutions, deletions, and insertions. In addition to the creation of DNA damage, asbestos exposed mesothelial cells continually proliferate via the NF-kB pathway [5].
In addition to asbestos exposure, chronic inflammation can induce mesothelial cells to undergo oncogenic transformation. Cases of pleural mesothelioma have been documented without asbestos exposure but were subject to recurrent lung infections, pulmonary tuberculosis, and recurrent pleural effusions. For testicular mesotheliomas, it is posited that long-standing hydroceles and persistent inflammation in the tunica vaginalis predispose individuals to mesothelioma [6].
When approaching a scrotal mass, a thorough history and physical exam is required. It is important to inquire about a family history of testicular cancer, previous inguinal hernia repair, cryptorchidism, and previous orchiopexy. When physical exam confirms a solid mass, trans-scrotal ultrasound is the primary imaging technique to further investigate the solid mass. Seminomas are the most common testicular carcinoma in men older than 35 and it is imperative to retrieve serum tumor markers, including αFP, LDH, and β-HCG [68]. In contrast to testicular masses, solid epididymal masses, however, are typically benign. The incidence of malignancy is correlated with epididymal mass size greater than 1.5 cm and is generally regarded as the cutoff for intervention [9].
Mesothelioma of the tunica vaginalis is a rare form of an already uncommon cancer. The majority of reported cases have been found incidentally during hydrocelectomies [10]. The presentation in this case report was atypical. Commonly patients present with risk factors for mesothelioma of the tunica vaginalis. Our patient presented with a long-standing painless testicular mass, lack of primary asbestos exposure and lack of a concomitant long-standing hydrocele. Moreover, he had no other sites of mesothelioma, indicating a primary mesothelioma of the tunica vaginalis of the testicle.
In conclusion, mesothelioma of the tunica vaginalis is a rare form of an already rare cancer. Despite having notable risk factors and found in conjunction with long-standing hydrocele it should be kept on the differential diagnosis when evaluating a middle-aged male presenting with a testicular mass.

Acknowledgements

Not applicable.

Declarations

Not applicable.
Written informed consent for publication of case report was obtained from the participant patient.

Competing interests

There was no funding for the study and no conflicts of interest to disclose.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Jetzt e.Med zum Sonderpreis bestellen!

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt bestellen und 100 € sparen!

e.Med Urologie

Kombi-Abonnement

Mit e.Med Urologie erhalten Sie Zugang zu den urologischen CME-Fortbildungen und Premium-Inhalten der urologischen Fachzeitschriften.

Literatur
3.
Zurück zum Zitat Chekol SS, Sun C-C (2012) Malignant mesothelioma of the tunica vaginalis testis: diagnostic studies and differential diagnosis. Arch Pathol Lab Med 136(1):113–117CrossRefPubMed Chekol SS, Sun C-C (2012) Malignant mesothelioma of the tunica vaginalis testis: diagnostic studies and differential diagnosis. Arch Pathol Lab Med 136(1):113–117CrossRefPubMed
10.
Zurück zum Zitat Drevinskaite M, Patasius A, Kevlicius L, Mickys U, Smailyte G (2020) Malignant mesothelioma of the tunica vaginalis testis: a rare case and review of literature. BMC Cancer 20(1):1–6CrossRef Drevinskaite M, Patasius A, Kevlicius L, Mickys U, Smailyte G (2020) Malignant mesothelioma of the tunica vaginalis testis: a rare case and review of literature. BMC Cancer 20(1):1–6CrossRef
Metadaten
Titel
Atypical presentation of testicular mesothelioma
verfasst von
Sawyer Joseph Reed
Stefanie Nasui
Nicholas Farber
Publikationsdatum
01.12.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
African Journal of Urology / Ausgabe 1/2023
Print ISSN: 1110-5704
Elektronische ISSN: 1961-9987
DOI
https://doi.org/10.1186/s12301-023-00402-1

Weitere Artikel der Ausgabe 1/2023

African Journal of Urology 1/2023 Zur Ausgabe

Patrone im Penis bringt Urologen in Gefahr

30.05.2024 Operationen am Penis Nachrichten

In Lebensgefahr brachte ein junger Mann nicht nur sich selbst, sondern auch das urologische Team, das ihm zu Hilfe kam: Er hatte sich zur Selbstbefriedigung eine scharfe Patrone in die Harnröhre gesteckt.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.